ALAR PHARMACEUTICALS INC.
Area: Government, Academia and Research Institutes
Booth No: N/A
Website: https://alarpharm.com/
Exhibitor Profile
Alar Pharmaceuticals Inc. focuses on developing innovative long-acting injectables (LAI) drug products for CNS disorders through the 505(b)(2) regulatory pathway. These formulations are designed to release the active ingredient steadily over a period ranging from several weeks to several months following single subcutaneous injection. Current product pipeline includes LAIs for opioid use disorder, alcohol use disorder, treatment-resistant depression, Parkinson’s disease, and schizophrenia.
Video
Exhibitors you may be interested in
Highest Rated
